To investigate the determinants of immune response and resistance within MMRd tumors, we utilized a murine colorectal cancer CT26 cell line, in which MSH2, a DNA mismatch repair protein, was either deleted or left intact, thereby modeling MMRd or MMRp tumors, respectively. This evidence concerns the gene MSH2 and colorectal cancer.